$ETST’s CEO, Dr. Michel Aubé expressed his optimism in the timing of the opportunities before the company, stating that the company, “will clearly be recognized as a leader in cannabinoids research and other health science research arena. Our future is shining bright.” With plenty of progress having been made in 2017, it will be exciting to watch how 2018 begins to unfold for this budding company.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!